Joji Shimono, Naoki Miyashita, Takahiro Sekine, Kohei Kasahara, Yasutaka Kakinoki (Hematology, Asahikawa city hospital, Asahikawa, Japan)
Session information
Oral Session
Oral Session 1-9B DLBCL: Prognostic Factors
Fri. Oct 11, 2019 10:10 AM - 11:10 AM No.9 (Tokyo International Forum, 4F G402)
Chair: Naoto Tomita (Division of Hematology and Oncology, Department of Internal Medicine , St. Marianna University School of Medicine)
Hideki Asaoku1, Takeshi Okatani1, Mitsuhiro Itagaki1, Yuta Katayama1, Ryota Imanaka1, Kohei Kyo1, Fumiaki Jinnouchi1, Takuya Nunomura1, Tatsuya Terasaki1, Shinya Katsutani3, Tsuyoshi Muta2, Koji Iwato3 (1.Dept. Hematology, Hiroshima RCH & ASH, Hiroshima, Japan, 2.Dept. Transfusion, Hiroshima RCH & ASH, Hiroshima, Japan, 3.Dept. Clinical labolatry, Hiroshima RCH & ASH, Hiroshima, Japan)
Hajime Senjo1,2, Kohei Okada2, Naoki Miyashita2, Shinpei Harada2, Tomohiro Yamakawa2, Junko Iwasaki2, Shojiro Takahashi2, Akio Shigematsu2, Koichiro Minauchi2, Naoki Kobayashi2, Masahiro Ogasawara2, Junichi Sugita1, Masahiro Imamura2, Shuichi Ota2, Daigo Hashimoto1, Takanori Teshima1 (1.Department of Hematology, Hokkaido University, Sapporo, Japan, 2.Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan)
Norihiro Ueda, Masato Zennami, Yasuko Torii, Yumi Ishiguri, Yoshiya Adachi, Rika Kihara, Koichi Watamoto (Department of Hematology, Komaki City Hospital)
Asuka Ogai1,2, Takahiro Kamiya1, Yuriko Fujita1, Masahiro Akimoto1, Tomohiko Tanigawa1, Shinji Ogura1, Chisako Ito1, Aki Sakurai1, Yoshinobu Aisa1, Tomonori Nakazato1 (1.Hematol., Yokohama Municipal Citizen's Hospital, 2.Internal. Med., Keiyu Hospital, Yokohama, Japan)
Kei Fujita, Eiju Negoro, Shin Lee, Takahiro Yamauchi (Department of Hematology and Oncology, University of Fukui, Fukui, Japan)